Literature DB >> 11181879

Azathioprine and interferon beta-1b treatment in relapsing-remitting multiple sclerosis.

C Milanese, L La Mantia, A Salmaggi, D Caputo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11181879      PMCID： PMC1737273          DOI： 10.1136/jnnp.70.3.413

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  4 in total

1.  Comparison of interferon beta products and azathioprine in the treatment of relapsing-remitting multiple sclerosis.

Authors:  M Etemadifar; M Janghorbani; V Shaygannejad
Journal:  J Neurol       Date:  2007-12-14       Impact factor: 4.849

Review 2.  Interferon-beta-1b: a review of its use in relapsing-remitting and secondary progressive multiple sclerosis.

Authors:  Paul L McCormack; Lesley J Scott
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

3.  Azathioprine versus beta interferons for relapsing-remitting multiple sclerosis: a multicentre randomized non-inferiority trial.

Authors:  Luca Massacesi; Irene Tramacere; Salvatore Amoroso; Mario A Battaglia; Maria Donata Benedetti; Graziella Filippini; Loredana La Mantia; Anna Repice; Alessandra Solari; Gioacchino Tedeschi; Clara Milanese
Journal:  PLoS One       Date:  2014-11-17       Impact factor: 3.240

Review 4.  Azathioprine. Safety profile in multiple sclerosis patients.

Authors:  L La Mantia; N Mascoli; C Milanese
Journal:  Neurol Sci       Date:  2007-12       Impact factor: 3.830
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.